ICD-10-CM Billable Code

C44.619

Basal cell carcinoma of skin of left upper limb, including shoulder

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) is the most common type of skin cancer. It develops from basal cells — small, round cells found in the lower part of the epidermis, the outer layer of the skin. When located on the skin of the left upper limb, including the shoulder, BCC presents specific considerations related to its appearance, risk factors, and treatment options. Despite its potential to grow locally and cause skin damage, BCC rarely spreads to other parts of the body. Recognizing and understanding this condition is essential for effective management and prompt medical attention.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) rays from sunlight or tanning beds. Fair skin, light hair, and light eye color increasing susceptibility. Chronic skin inflammation or scars that have been exposed repeatedly to UV radiation. A history of skin cancer or genetic predisposition such as basal cell nevus syndrome. Weakened immune system, including immunosuppressive therapy or conditions affecting immunity.

Key Symptoms: A persistent, shiny, and translucent bump on the skin that may be pink, red, or flesh-colored. A lesion with a rolled border, sometimes featuring small blood vessels on the surface. An open sore that heals and then re-opens, often with a crusted surface. Or a scar-like area that appears pink, white, or translucent and may be slightly raised or indented. Slow-growing nature, with the lesion enlarging gradually over months or years.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a clinical examination where a healthcare provider assesses the skin lesion's appearance. A skin biopsy, where a small sample of skin is taken and examined microscopically, confirms the diagnosis. Additional imaging tests might be performed if there’s concern about deeper tissue involvement. Early detection through regular skin checks enhances the effectiveness of treatment and preserves skin integrity.

Treatment Protocols: Surgical excision: The most common and effective treatment method, removing the cancerous tissue along with a margin of healthy skin. Mohs micrographic surgery: A precise surgical technique that minimizes removal of healthy tissue, ideal for facial areas but also applicable to other locations. Cryotherapy: Freezing the lesion with liquid nitrogen to destroy cancer cells, suitable for small or superficial BCCs. Topical medications: Such as imiquimod or 5-fluorouracil, used for superficial BCCs in select cases. Radiation therapy: Used when surgery isn’t possible or for cases where residual cancer remains after excision. Photodynamic therapy: A treatment combining a photosensitizing agent with light exposure, effective for superficial BCCs.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.619 a billable ICD-10 code?
Yes, C44.619 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.619?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of left upper limb, including shoulder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference